SCHEMBL693886

SCHEMBL693886

Fc1c[c]ccc1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
PTGS1 P23219 3/20 0.35
PTGS2 P35354 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
FABP2 P12104 1/20 0.35
TSHR P16473 1/20 0.35
AKR1C4 P17516 1/20 0.35
ADRA2B P18089 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2C P28335 1/20 0.35
DRD3 P35462 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29246765 0.98 PTGS1 (0.34) MEN1KMT2APTGS1PTGS2HPGD
SCHEMBL28530737 0.92 ALDH1A1 (0.33) MEN1KMT2APTGS1PTGS2HPGD
SCHEMBL4319544 0.86
SCHEMBL5116498 0.83 BACE1 (0.34) MEN1KMT2APTGS1PTGS2HPGD
SCHEMBL150097 0.83 PTGS2 (0.35) PTGS1PTGS2CYP2C9CYP2C19RPS6KA3
SCHEMBL2886283 0.81
SCHEMBL4209132 0.80 TAAR1 (0.40) MEN1KMT2AHPGDMAPT
SCHEMBL434024 0.80 KDM4E (0.34) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL618853 0.79 BACE1 (0.39) PTGS2HPGDBACE1ALDH1A1HSD17B10
SCHEMBL15286357 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654610-A Pyrazole and imidazole compounds for inhibiting IL-17 and ROR gamma 里亚塔医药公司 2021-04-13 CN claimed
US-10076517-B2 Methods and pharmaceutical compositions for the treatment of fibrosis INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE KA RECHERCHE MÉDICALE (FR) 2018-09-18 US claimed
WO-2015114030-A1 ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF HEART DISEASES GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS, UNIVERSITÄTSMEDIZIN (DE) 2015-08-06 WO claimed
US-8815839-B2 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2014-08-26 US claimed
EP-2421825-B9 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-20 EP claimed
US-8691805-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2014-04-08 US claimed
EP-2421825-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-01-01 EP claimed
US-20130244997-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (US) 2013-09-19 US claimed
US-20130184251-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2013-07-18 US claimed
US-8455476-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2013-06-04 US claimed
WO-1987000519-A1 CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS THE UPJOHN COMPANY (US) 1987-01-29 WO claimed
EP-0207622-A2 Benzothiazine dioxide derivatives PFIZER INC. (US) 1987-01-07 EP claimed
US-4610982-A Anti-inflammatory benzo- and thieno-1,2-thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor PFIZER INC. (US) 1986-09-09 US claimed
US-4601797-A Electrochemical carboxylation of p-isobutylacetophenone and other aryl ketones MONSANTO COMPANY (US) 1986-07-22 US claimed
US-4188491-A PREPARING 2-(4-BIPHENYLYL)PROPIONIC ACIDS BY REACTING BIPHENYLYLMAGNESIUM BROMIDES WITH SODIUM PYRUVATE, ACIDIFYING THE BOOTS COMPANY LIMITED (GB) 1980-02-12 US claimed
US-4107439-A Process for preparing arylalkanoic acid derivatives THE UPJOHN COMPANY (US) 1978-08-15 US claimed
US-4096338-A ANTIPHLOGISTIC NISSHIN FLOUR MILLING CO., LTD. (JA) 1978-06-20 US claimed
US-4042617-A FROM A GLYCIDIC ACID ESTER NISSHIN FLOUR MILLING CO., LTD. (JA) 1977-08-16 US claimed
US-4016196-A HEATING GLYCIDIC ESTERS NISSHIN FLOUR MILLING CO., LTD. (JA) 1977-04-05 US claimed
US-4007217-A FROM A GLYCIDATE NISSHIN FLOUR MILLING CO., LTD. (JA) 1977-02-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10076517-B2 Methods and pharmaceutical compositions for the treatment of fibrosis LIPA, MGLL, PNLIP MEN1 3362/4885KMT2A 2612/4885PTGS1 422/4885
US-20130244997-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA MEN1 1953/4885KMT2A 1573/4885PTGS1 376/4885
US-20130184251-A1 HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS MGLL, PNLIP, LIPC MEN1 4471/4885KMT2A 780/4885PTGS1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.